摘要
目的探讨在病毒性心肌炎的治疗上芪冬颐心口服液的治疗效果,为其临床应用提供可靠依据。方法将2014年2月—2015年2月,在重庆市人民医院进行治疗的100例病毒性心肌炎患者,随机分为芪冬颐心口服液治疗研究组（50例）和常规西医治疗对照组（50例）,15 d为1个疗程,比较两组患者服药后的总有效率、收缩压、心率和心肌耗氧量,以及药物不良反应等。结果治疗组总有效率为96%,对照组为66%,前者明显高于后者,差异有统计学意义（χ~2=14.62,P〈0.05）,且治疗组患者在心率（76.7±7.0）次/min和心肌耗氧量（9 127±1 002）上均比对照组[（79.1±8.2）次/min,（9 333±986）]的改善情况更佳,差异有统计学意义（P〈0.05）。结论芪冬颐心口服液对病毒性心肌炎的治疗效果,明显优于单用常规西药,具有效果显著,安全性高,临床上可以考虑进行选择及更加广泛的推广。
Objective To investigate the treatment of clinical effect of Qidongyixin oral liquid for viral myocarditis,and provide a reliable basis for its clinical application.Methods 100 cases of viral myocarditis were collected in Chongqing Municipal People’s Hospital from February 2014 to February 2015.Then they were randomly divided into two groups,the control group and treatment group,50 cases in each group.The former was given conventional therapy,the latter took extra Qidongyixin oral liquid treatment on the basis of the control group.The total effective rate,systolic blood pressure,heart rate and myocardial oxygen consumption,and adverse drug reactions were compared between the two groups.Results By statistical analysis,the effective rate of the group which was taking Qidongyixin oral liquid,was 96%,significantly better than the control group 66%,the difference was statistically significant（χ~2=14.62,P 〈0.05）.Moreover,the patients’ heart rate（76.7 ±7.0）times/min and myocardial oxygen consumption（9 127 ±1 002） in the treatment group were also significantly better than that of control group[（79.1±8.2）times/min,（9 333±986）],the difference was statistically significant（P〈0.05）.Conclusion Qidongyixin oral liquid can significantly improve the symptoms of patients with viral myocarditis,the clinical treatment effect is obvious.
出处
《世界复合医学》
2016年第4期34-37,共4页
World Journal of Complex Medicine
关键词
芪冬颐心口服液
病毒性心肌炎
临床疗效
Qidongyixin oral liquid
Viral myocarditis
Clinical curative effect
